2014 annual financial data

Galectin Therapeutics 2014 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -15,430,000 USD and net income was -15,788,000 USD.
Operating cash flow was -12,426,000 USD.

Get free Galectin Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-15,430,000 USD
Net income
-15,788,000 USD
Operating cash flow
-12,426,000 USD